Literature DB >> 15950574

Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data).

Anthony A Bavry1, Dharam J Kumbhani, Thomas J Helton, Deepak L Bhatt.   

Abstract

We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15950574     DOI： 10.1016/j.amjcard.2005.02.015

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.

Authors:  S Sidhu; N Shafiq; S Malhotra; P Pandhi; A Grover
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

2.  Late adverse events after drug-eluting stent implantation.

Authors:  David F Kong; Eric L Eisenstein; Robert Harrington
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

Review 3.  Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Authors:  Teruo Inoue; Kevin Croce; Toshifumi Morooka; Masashi Sakuma; Koichi Node; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2011-10       Impact factor: 11.195

4.  The dawn of neurosurgery in pre-conquest Mesoamerican territories.

Authors:  Graciela Zuccaro
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

5.  Liposomal simvastatin attenuates neointimal hyperplasia in rats.

Authors:  Eyal Afergan; Meital Ben David; Hila Epstein; Nickolay Koroukhov; Dalia Gilhar; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

6.  Stent thrombosis: understanding and managing a critical problem.

Authors:  Julio F Marchini; Andre Manica; Kevin Croce
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

7.  Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.

Authors:  Hai-Tao Liu; Fei Li; Wen-Yong Wang; Xiao-Jing Li; Yi-Meng Liu; Rui-An Wang; Wen-Yi Guo; Hai-Chang Wang
Journal:  Tex Heart Inst J       Date:  2010

8.  A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.

Authors:  Volker Pönitz; José W Govers-Riemslag; Hugo Ten Cate; Rene van Oerle; Trygve Brügger-Andersen; Heidi Grundt; Patrycja Næsgaard; David Pritchard; Alf I Larsen; Dennis W Nilsen
Journal:  Thromb J       Date:  2010-04-15

9.  Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.

Authors:  Ailiman Mahemuti; Nicolas Meneveau; Marie-France Seronde; Francois Schiele; Vincent Descotes-Genon; Fiona Ecarnot; Marie-Cecile Blonde; Mariette Mercier; Evelyne Racadot; Jean-Pierre Bassand
Journal:  J Thromb Thrombolysis       Date:  2008-09-03       Impact factor: 2.300

10.  Role of magnolol in the proliferation of vascular smooth muscle cells.

Authors:  L Wu; H Zou; W Xia; Q Dong; L Wang
Journal:  Herz       Date:  2014-03-06       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.